Results 191 to 200 of about 3,046,243 (224)

Relation of <i>JAK2</i> V617F allele burden and coronary calcium score in patients with essential thrombocythemia. [PDF]

Radiol Oncol
Drofenik A, Blinc A, Bozic Mijovski M, Pajic T, Vrtovec M, Sever M.   +5 more
europepmc   +1 more source

Detecting Multiple Driver Mutations in a Patient with Essential Thrombocythemia. [PDF]

Am J Case Rep
Sharma S, Morisetti M, Gandhi N, Chennapragada SS, Cotelingam JD, Ramadas P.   +5 more
europepmc   +1 more source

Initiating-clone analysis in patients with acute myeloid leukemia secondary to essential thrombocythemia. [PDF]

Sci Rep
Ushijima Y, Naruse S, Ishikawa Y, Kawashima N, Sanada M, Nakashima M, Kim JH, Terakura S, Kihara R, Watamoto K, Nishiyama T, Kitamura K, Matsushita T, Kiyoi H.   +13 more
europepmc   +1 more source

A rare case of concurrent JAK2V617F-positive essential thrombocythemia, multiple myeloma, and colorectal adenocarcinoma

Fenghong Zhang, Yu Chen, Dongping Huang, Suning Chen   +3 more
openalex   +1 more source

Queries regarding the two papers each reporting on 1000 essential thrombocythemia patients in BCJ. [PDF]

Blood Cancer J
Ellis MH.
europepmc   +1 more source

Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk‐stratification and management

American Journal of Hematology, 2020
Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms (MPN) respectively characterized by clonal erythrocytosis and thrombocytosis; other disease features include leukocytosis, splenomegaly, thrombosis, bleeding ...
Ayalew Tefferi, Tiziano Barbui
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Essential thrombocythemia: challenges in clinical practice and future prospects.

Blood, 2022
Essential thrombocythemia (ET) was described in 1934 and in the intervening time progress has been achieved in better understanding molecular pathogenesis and which patients may have greatest risk of progression or vascular events.
A. Godfrey, A. Green, C. Harrison
semanticscholar   +1 more source

Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis

Blood Advances, 2019
In the last years, a growing amount of evidence has been produced regarding the role of leukocytosis as a risk factor for thrombosis in patients with myeloproliferative neoplasms, predominantly in polycythemia vera (PV) and essential thrombocythemia (ET).
Alessandra Carobbio, Alberto Ferrari, Giovanni Barosi   +2 more
exaly   +2 more sources

A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis

Leukemia, 2017
Francesco Passamonti, Toni Giorgino, Paola Guglielmelli   +2 more
exaly   +2 more sources